Azabicyclo derivatives as muscarinic receptor antagonists
US7446123B2 · kind B2 · utility
0Cited by
13References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2004 |
| Grant date | Nov 4, 2008 |
| Priority date | — |
| Expiry date | Jan 7, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention generally relates to muscarinic receptor antagonists of formula (I) which are useful, among other uses for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.